Krystal Biotech (KRYS) Assets Growth (5y) (2021 - 2026)
Powered by 
Analysis
Krystal Biotech (KRYS) Assets Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.06 Bn | 3.06 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.68 Bn | 2.68 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.55 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.99 Bn | 1.99 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.60% |
| Mar 31, 2026 | 25.82% |
| Dec 31, 2025 | 33.82% |
| Sep 30, 2025 | 31.83% |
| Mar 31, 2025 | 39.26% |
| Dec 31, 2024 | 38.25% |
| Sep 30, 2024 | 35.60% |
| Jun 30, 2024 | 34.93% |
| Mar 31, 2024 | 49.12% |
| Dec 31, 2023 | 47.78% |
| Sep 30, 2023 | 70.75% |
| Jun 30, 2023 | 71.56% |
| Mar 31, 2023 | 61.87% |
| Dec 31, 2022 | 61.96% |
| Sep 30, 2022 | 61.37% |
| Dec 31, 2021 | 210.16% |